| |
|
|
|
Cancer Genetics Inc  
|
|
2.9 -0.02 (-0.01%) |
08-05 16:00 |
|
Open: |
2.9529 |
Pre close: |
2.92 |
Target:
|
3.67
|
|
High: |
2.9529 |
Low: |
2.89 |
Resistance:
|
3.14
3.41
|
|
Volume: |
18,940 |
Market Cap: |
7M |
Support:
|
2.70
2.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.93
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
3.03 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
3.03  |
Stochastic Oscillator |
%K(14,3):
|
20.52 |
|
MA(250): |
3.77 |
%D(3): |
25.33 |
|
Average Volume(K) |
3-Month: |
6657
|
52-Week |
High:
|
9.50 |
|
10-Days: |
2541 |
Low: |
1.92 |
|
RSI |
RSI(14):
|
43.24 |
Change(%): |
-25.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.598 |
Return on Equity (ttm) |
-90.1 |
Shares Out. (M) |
2.26 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-6.7 |
Shares Float (M) |
2.01 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.38 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-21.7 |
% Held by Institutions |
15.06 |
|
Forward EPS |
-0.750 |
Gross Profit (p.s.) |
1.593 |
Shares Short (K) |
24 |
|
Book Value (p.s.) |
3.030 |
EBITDA (p.s.) |
-0.965 |
P/E |
-1.81 |
|
Sales Per Share |
3.058 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.96 |
|
Profit Margin |
-47.33 |
Operating Cash Flow
(M) |
-4.36 |
P/S |
0.95 |
|
Operating Margin |
-40.93 |
Levered Free Cash Flow
(M) |
-3.28 |
P/CF |
-1.50 |
|
|
|
|
|
|
